Related references
Note: Only part of the references are listed.A detail survey and analysis of selectivity criteria for indole-based histone deacetylase 8 (HDAC8) inhibitors
Md. Moinul et al.
JOURNAL OF MOLECULAR STRUCTURE (2023)
Insight into the structural requirements of gelatinases (MMP-2 and MMP-9) inhibitors by multiple validated molecular modelling approaches: Part II
S. Das et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2022)
Identification of potent inhibitors against chorismate synthase of Toxoplasma gondii using molecular dynamics simulations
Samayaditya Singh et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2022)
An Epigenetic Role of Mitochondria in Cancer
Yu'e Liu et al.
CELLS (2022)
Development of decision trees to discriminate HDAC8 inhibitors and non-inhibitors using recursive partitioning
Sk Abdul Amin et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
From natural products to HDAC inhibitors: An overview of drug discovery and design strategy
Xiang Qiu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Synthesis of nigranoic acid and manwuweizic acid derivatives as HDAC inhibitors and anti-inflammatory agents
Dong-Xuan Ni et al.
BIOORGANIC CHEMISTRY (2021)
Development of Coumarin-Based Hydroxamates as Histone Deacetylase Inhibitors with Antitumor Activities
Na Zhao et al.
MOLECULES (2020)
Identification of structural fingerprints for ABCG2 inhibition by using Monte Carlo optimization, Bayesian classification, and structural and physicochemical interpretation (SPCI) analysis
K. Ghosh et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2020)
Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase 1 (HDAC1) Dual Inhibitors Derived from the Natural Product Saprorthoquinone
Yang Lin et al.
MOLECULES (2020)
Histone Deacetylase Inhibitors from Marine Invertebrates
Claudio Luparello et al.
BIOLOGY-BASEL (2020)
Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities
Feifei Yang et al.
MOLECULES (2019)
Reliable structural information for rational design of benzoxazole type potential cholesteryl ester transfer protein (CETP) inhibitors through multiple validated modeling techniques
Sk. Abdul Amin et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells
Yong Ling et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Natural Agents-Mediated Targeting of Histone Deacetylases
Ammad Ahmad Farooqi et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)
3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors
Tooba Abdizadeh et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2017)
Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential
Anna Kazanets et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
Common SAR Derived from Multiple QSAR Models on Vorinostat Derivatives Targeting HDACs in Tumor Treatment
Sugathan Praseetha et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Modelling the cytotoxic activity of pyrazolo-triazole hybrids using descriptors calculated from the open source tool PaDEL-descriptor
Sk. Abdul Amin et al.
JOURNAL OF TAIBAH UNIVERSITY FOR SCIENCE (2016)
Natural Products as Zinc-Dependent Histone Deacetylase Inhibitors
Shuai Tan et al.
CHEMMEDCHEM (2015)
Discovery of Novel Class I Histone Deacetylase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities
Yiwu Yao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population
Ser Yeng Ler et al.
ONCOLOGY REPORTS (2015)
An Overview of Naturally Occurring Histone Deacetylase Inhibitors
Bumki Kim et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Evaluation of class I HDAC isoform selectivity of largazole analogues
Bumki Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
CKIP-1 suppresses the adipogenesis of mesenchymal stem cells by enhancing HDAC1-associated repression of C/EBPα
Dahu Li et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
A novel two-step QSAR modeling work flow to predict selectivity and activity of HDAC inhibitors
Lingling Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
ADME Evaluation in Drug Discovery. 10. Predictions of P-Glycoprotein Inhibitors Using Recursive Partitioning and Naive Bayesian Classification Techniques
Lei Chen et al.
MOLECULAR PHARMACEUTICS (2011)
Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
Teppei Yamaguchi et al.
GENES & DEVELOPMENT (2010)
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Julia M. Wagner et al.
Clinical Epigenetics (2010)
Novel Inhibitors of Human Histone Deacetylase (HDAC) Identified by QSAR Modeling of Known Inhibitors, Virtual Screening, and Experimental Validation
Hao Tang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
Florian R. Fritzsche et al.
BMC CANCER (2008)
Chemistry, biology, and QSAR studies of substituted biaryl hydroxamates and merca ptoacetamides as HDAC inhibitors - Nanomolar-potency inhibitors of pancreatic cancer cell growth
Alan R. Kozikowski et al.
CHEMMEDCHEM (2008)
Residues in the 11 A channel of histone deacetylase 1 promote catalytic activity: Implications for designing isoform-selective histone deacetylase inhibitors
Sujith V. W. Weerasinghe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Identification of ligand features essential for HDACs inhibitors by pharmacophore modeling
Ya-dong Chen et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2008)
Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?
T. C. Karagiannis et al.
LEUKEMIA (2007)
Histone deacetylase 3 (HDAC3) and other class IHDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer
AJ Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA
KB Glaser et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex
N Wiper-Bergeron et al.
EMBO JOURNAL (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
Share Paper
